OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Favipiravir for treating COVID-19
Pritish John Korula, Hanna Alexander, Jisha Sara John, et al.
Cochrane library (2024) Vol. 2024, Iss. 2
Open Access | Times Cited: 10

Showing 10 citing articles:

Clinical characteristics, outcomes, and costs of COVID-19 patients in Thai hospitels: a comparative analysis based on chest X-ray findings
Naruemit Sayabovorn, Pochamana Phisalprapa, Weerachai Srivanichakorn, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access

The Impact and Evolution of COVID-19 on Liver Transplant Recipients Throughout the Pandemic “Waves” in a Single Center
Clara Fernández Fernández, Blanca Otero Torrón, Mercedes Bernaldo de Quirós Fernández, et al.
Viruses (2025) Vol. 17, Iss. 2, pp. 273-273
Open Access

Favipiravir-RTP as a Potential Therapeutic Agent for Inhibiting Dengue Virus Replication
Pui-Jen Tsai
Journal of Biosciences and Medicines (2025) Vol. 13, Iss. 02, pp. 268-286
Open Access

Viral replication organelles: the highly complex and programmed replication machinery
Hao Deng, Hongwei Cao, Yanjin Wang, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 1

Influence of chronic liver diseases on the course and outcome of COVID-19
Nikola Mitrović, Milos Sabanovic, Ankica Vujović, et al.
PLoS ONE (2023) Vol. 18, Iss. 7, pp. e0288350-e0288350
Open Access | Times Cited: 3

Predictions in Clinical Efficiency of SARS-CoV-2 RNA-Dependent RNA Polymerase (RdRp) Inhibitors by Molecular Docking
Pui-Jen Tsai
Journal of Biosciences and Medicines (2024) Vol. 12, Iss. 10, pp. 178-196
Open Access

What are the effects of favipiravir for treating adults with COVID-19?
Amin Sharifan
Cochrane Clinical Answers (2024)
Closed Access

Assessing Favipiravir's Impact on SARS-CoV-2 Transmission within Households: Insights from a Multi-center Study (FaviPrev)
Taweegrit Siripongboonsitti, Marisa Muadchimkaew, Kriangkrai Tawinprai, et al.
Journal of Virus Eradication (2024) Vol. 10, Iss. 4, pp. 100576-100576
Open Access

The Ability of Combined Flavonol and Trihydroxyorganic Acid to Suppress SARS-CoV-2 Reproduction
Andrey Bogoyavlenskiy, Pavel Alexyuk, Madina Alexyuk, et al.
Viruses (2024) Vol. 17, Iss. 1, pp. 37-37
Open Access

Page 1

Scroll to top